hatch-waxman act and amendments

0:05:50

Para four filing procedure, and 180 days Exclusivity

0:10:45

2. The Hatch Waxman Act with reference to generic Drugs, The Orange book

0:00:48

35 Year Anniversary of Generic Medicines

0:06:30

Drug Price Competition and Patent Term Restoration Act | Wikipedia audio article

0:35:46

Patents (Amendment) Rules, 2016

0:03:05

Hatch Act

0:52:54

Changes to Orange Book Patent Information

0:01:31

Orphan Drug Exclusivity vs New Chemical Exclusivity

0:05:01

Regulatory Affairs

1:00:27

Generics—Anything But Generic! Understanding the Unknowns and Pricing of Generic Drugs

0:26:24

Why are Brand Name Drugs more Expensive than Generics? | Patrick Kelly

0:02:22

What is the Biologics Price Competition and Innovation Act (BPCIA) and when was it enacted?

0:59:17

505 (b)(2) Regulatory Pathway: Generic Drug Development Strategies

0:46:19

Webinar : Hot Topics in Generic Drug Entry and Regulation

0:02:41

Paragraph IV Patent Protection and Litigation CLE

0:00:52

Generic Medicines 35th Birthday Celebration

0:00:49

Drug Price Competition and Patent Term Restoration Act Top # 6 Facts

1:00:50

Recent Developments and Trends in ANDA Litigations

0:02:10

James Shehan, JD: The FDA and Citizen Petitions

0:35:55

Reining in prescription drug prices: The politics of prescription drugs

0:00:49

Advocates Amendment Act 2023

0:21:54

30 Regulatory Affairs Job Interview Question & Answer for Freshers

0:08:15

The Hatch Act Explained

0:39:50

Orange Book Exclusivity: Part III - 180-Day and Competitive Generic Therapy Exclusivities